Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

Scientists at Colossal Biosciences have created stem cells from the Asian elephant which can potentially be reprogrammed into sperm and egg cells of a hairy, cold-resistant elephant. A pioneer in the ...

Embryonic stem cells (ESCs) exhibit unique chromatin features, including a permissive transcriptional program and an open, decondensed chromatin state. Induced pluripotent stem cells (iPSCs), which ...

The results could shed light on why the animals rarely get cancer. But the researchers’ ultimate goal of bringing back woolly mammoths is still aspirational. By Carl Zimmer When the biotechnology firm ...

Colossal Biosciences creates technologies for species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth.

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...

Researchers in Japan have developed a form of stem cell therapy that "reverses" paralysis. Though the treatment has only seen a 50% success rate so far, two of the four people who received it have ...